ArticleInternational journal of molecular sciences2026
Spermine: A Hemoglobin Modifier That Reduces Autoxidation and Regulates Oxygen Delivery.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the major factors currently hindering the development of hemoglobin-based oxygen carriers (HBOCs) is the autoxidation of hemoglobin to inactive methemoglobin (MetHb). The effects of spermine on the stability, aggregation, structure, and function of adult hemoglobin (HbA) were studied. The interaction of spermine with HbA was elucidated by dynamic light scattering, colloid osmotic pressure measurements, thermal denaturation analysis, static light scattering, and oxygen dissociation assay. The antioxidant capacity of spermine was confirmed through UV-vis spectroscopic recordings, calculations of MetHb formation, and hydroxyl radical scavenging. The P50 value was determined by the oxygen dissociation curve to investigate the roles of spermine in increasing HbA's oxygen affinity. The pH-dependent affinity between spermine and HbA was validated through surface plasmon resonance experiments. The transformation of HbA's partial α-helix to a β-sheet structure induced by spermine was clarified using a microfluidic modulation spectrometer. The binding of spermine to βASP99, βGLU101, αTHR38, and αASN97 on HbA and the conformational shift in HbA towards the 'R' state were investigated via molecular docking and molecular dynamics simulations. In a word, spermine can enhance the oxygen affinity of HbA, effectively reduce autoxidation, and hold promise for applications in the research of HBOCs or hemoglobin modification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.